Use the statistic functions workspace to apply Beta function and other studies to CareDx. It emphasizes statistical functions describing dispersion and variability while keeping volatility, risk, and performance context in view.Enter Time Period to run this model.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on CareDx Inc correlated with the market. If Beta is less than 0 CareDx generally moves in the opposite direction as compared to the market. If CareDx Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CareDx Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CareDx is generally in the same direction as the market. If Beta > 1 CareDx moves generally in the same direction as, but more than the movement of the benchmark.
CareDx Technical Analysis Modules
Most technical analysis of CareDx help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CareDx from various momentum indicators to cycle indicators. When you analyze CareDx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. The company was incorporated in 1998 and is headquartered in South San Francisco, California. CareDx operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 633 people. The stock overview for CareDx summarizes business drivers, financial profile, and market behavior. The company is positioned within Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Current metrics include P/B of 2.9, profit margin of -5.62%. CareDx has a market cap of 882.07 M, ROE of -6.27%.
Methodology
Unless otherwise specified, financial data for CareDx Inc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. CareDx (USA Stocks:CDNA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for CareDx Inc is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
CareDx Inc may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Tracking CareDx inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Generate Optimal Portfolios
Align your risk and return expectations
By capturing risk tolerance and investment horizon, Macroaxis optimization evaluates acceptable risk for target return profiles. The process summarizes how much risk can be taken for a given return goal.
A comprehensive view of CareDx Inc starts with financial statements and ratio context. Financial ratios provide context for profitability, efficiency, and growth trends. Outlined below are key reports that provide context for CareDx Inc Stock:
CareDx has a market cap of 882.07 M, operating margin of -3.49%, ROE of -6.27%. See Trending Equities for portfolio-level analysis. This suggests a position in CareDx Inc within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Analysis related to CareDx should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Earnings Share
-0.40
Revenue Per Share
7.127
Quarterly Revenue Growth
0.252
Return On Assets
-0.03
Return On Equity
-0.06
Understanding CareDx Inc includes distinguishing between market value and book value, where book value reflects CareDx's accounting equity. CareDx's market capitalization is 882.07 M. A P/B ratio of 2.9 indicates the market values CareDx above its accounting book value. Enterprise value stands at 727.35 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for CareDx differs from its quoted price, since each reflects a different lens. For CareDx, key inputs include a P/B ratio of 2.9, a profit margin of -5.62%, ROE of -6.27%, and revenue of 379.81 M. Trading price represents the transaction level agreed by market participants.